ARCHIVES

DC E Bard Approves Health Plan Study Recompetition, New Acrylonitrile Contract

This article is from The Cancer Letter archive.

Vol. 10 No. 11 | March 16, 1984

Download PDF Visit The Full Archive

Related Articles

Also R01 payline likely to fall below 20th percentile in FY04.

September 26, 2003

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

Nine New Grants Awarded In The NCI “Director’s Challenge”.

October 13, 2000

What Is and Isn’t a Crime in Texas: CPRIT Official Indicted For Skipping Peer Review

December 13, 2013

NCAB Calls For Modification Of Rules For NIH Scientist-Industry Collaboration

December 10, 2010